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The tuberculin skin test (TST) and interferon gamma (IFN-γ) release assay (IGRA) have been widely used for diagnosis 
of latent tuberculosis infection (LTBI). In order to overcome limitations of current LTBI diagnostic methods, the development 
of a novel molecular assay which is able to measure the IFN-γ messenger RNA (mRNA) expression level after stimulation 
with Mycobacterium tuberculosis (MTB) specific antigen was recently developed. The ability of a molecular assay to 
detect MTB infection was similar to commercial IGRA however, the optimal incubation time for stimulating IFN-γ was 
not yet established. Therefore, in this study the direct comparisons of MTB Ag stimulation times (4 and 24 hrs) were 
performed for diagnosis of MTB infection. Data showed that the coincident rate between QFT-GIT IFN-γ ELISA and 
IFN-γ RT-PCR (4 hrs) was 88.35% and that of QFT-GIT and IFN-γ RT-PCR (24 hrs) was 70.85%. Based on a receiver 
operating characteristic (ROC) curve, the 4 hrs-MTB specific Ag stimulation time for IFN-γ RT-PCR had the significant 
P value, 95% CI value, and AUC (P < 0.0001, 95% CI=0.82 to 1.02, and AUC=0.9214) in comparison with 24 hrs-MTB 
specific Ag stimulation time (P = 0.009, 95% CI=0.06 to 0.94, and AUC=0.7711). These results show that 4-hr was the 
most optimal MTB Ag stimulation time for performing IFN-γ RT-PCR. Although semi-quantitative RT-PCR had a few 
analytical limitations, it might be useful as an alternative molecular diagnostic method for detecting MTB infection.  
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INTRODUCTION
Tuberculosis (TB) is mainly caused by Mycobacterium 
tuberculosis (MTB) and remains a major infectious 
disease because it causes the highest mortality among the 
infectious diseases (Lier EA et al, 2007). Global TB 
control has been difficult because it is usually transmitted 
by airborne infection and recent globalization of the 
world population. According to the WHO report, 
therefore, one third of world population has infected with 
MTB (WHO, 2010). In the past, outbreaks of TB was 
mainly occurred in developing countries however, the TB 
occurrence in developed countries is increasing because 
of the increase of HIV co-infection, elderly population, 
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and immunosuppressive therapy. Those factors elevate the 
possibility to develop the active TB disease.
Latent TB infection (LTBI) is a state in which MTB 
persists within its host without causing clinical symptom, 
and signs with acid fast bacilli (AFB) stain negative and 
chest X-ray normality (Mack U et al., 2009; Hanif E et 
al., 2012). Latently infected population has a potential 
risk of developing active disease according to the hosts’ 
immune or nutritional condition in their lifetime, 
therefore, accurate diagnosis and therapy of LTBI might 
be the most important thing to control TB in developed 
countries (Comstock GW et al., 1974; Hong JY et al., 
2012). 
There are two available LTBI diagnostic methods; 
tuberculin skin test (TST) and interferon gamma release 
assay (IGRA), however, there is no gold standard 
diagnostic method for detecting LTBI. TST measures the 
hosts’ delayed-type hypersensitivity after injection of 
MTB purified protein derivative (PPD). It has been 
widely used for over 200 years with inexpensive cost, 
however, it has shown false-positive results in NTM 
exposed and BCG vaccinated populations (Pouchot J et 
al., 1997). IGRA assesses the presence of MTB infection 
by detecting the ex vivo release of IFN-γ following 
stimulation with MTB-specific antigens (Ags), such as 
early secretory Ag target 6 (ESAT-6) and culture filtrate 
protein 10 (CFP-10) which are strong targets of T-cells 
in MTB infection, but also absence in all BCG strains 
and the major environmental NTM (Lalvani A., 2001). 
IGRA uses IFN-γ monoclonal antibody and MTB- 
specific Ags. The cost of IGRA is expensive compared 
to TST, but the use of IGRA is recently increasing 
because the specificity and sensitivity were significantly 
higher in IGRA (Sester M et al., 2011; Diel R et al., 
2010). However, it has shown several limitations. For 
instance, they are labor-intensive, sensitivity limitation, 
and IFN-γ ELISA (except IFN-γ ELISPOT) which does 
not consider the number of T cells contained in whole 
blood (Mandalakas AM et al., 2008). In order to 
overcome limitations of IGRA, a molecular diagnostic 
assay using IFN-γ mRNA real-time RT-PCR was 
developed (Kim et al., 2013). According to data from the 
previous study, MTB specific Ag stimulation time could 
be shorten from 24 hr to 4 hr for performing real-time 
RT-PCR targeting IFN-γ mRNA. Additionally, the 
sensitivity and specificity of the molecular assay was 
similar to commercial IGRA (Kim et al., 2012). 
However, it has not shown a direct comparison of Ag 
stimulation time between 4 and 24 hr for IFN-γ 
molecular assay. 
In this study, RT-PCR targeting IFN-γ mRNA was 
performed with whole blood samples from active TB 
patients and a non-TB group. For IFN-γ mRNA RT-PCR, 
whole blood was stimulated with MTB-specific Ags for 
4 and 24 hr (two time point) and, the results of IFN-γ 
mRNA RT-PCR were compared with commercial IGRA 
(QFT-GIT) and clinical diagnosis.
MATERIALS AND METHODS
Study subjects
This study was carried out since May 2010 until Aug 
2010 at Yonsei University Wonju Severance Christian 
Hospital with 39 study subjects (12 active TB and 27 
non-TB) who have clinical symptoms of any infectious 
disease. Whole blood used in this study was collected 
from 39 study subjects. All subjects provided written 
informed consent, and the study was approved by the 
Institutional Ethics Committee of Yonsei University 
Wonju College of Medicine (approval no. 2010-21).  
T-cell mitogen (PHA) and MTB specific Ag 
stimulation
Ag stimulation was performed using the commercial Ag 
tubes, QFT-GIT test (Cellestics, Vic, Australia), according 
to the manufacturer’s instructions (Mori T et al., 2004; 
Harada N et al., 2008). Blood samples were collected into 
three QFT-GIT collection tubes (Nil, MTB specific Ags, 
and Mitogen). For IFN-γ mRNA RT-PCR, Ag stimulation 
was performed for both 4 hr and 24 hr at 37℃. For 
QFT-GIT IFN-γ ELISA, stimulation was performed for 16 
to 24 hr at 37℃. Plasma was collected by centrifugation 
at 2,000 xg for 5 min and stored at -80℃ until it was 
assayed QFT-Gold ELISA. 
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IFN-γ ELISA(QuantiFERON-TB Gold In-tube test)
IFN-γ concentrations in plasma samples from each 
subject were determined using the QFT-GIT ELISA test 
according to the procedure enclosed in the product insert. 
The ELISA assay was carried out by trained staff at 
Yonsei University Wonju Severance Christian Hospital, 
Wonju, Republic of Korea. The test results were 
interpreted using QFT-GIT ELISA software (version no. 
2.43; Cellestis Ltd., Vic, Australia) and the cut-offs for 
diagnosis in the manufacturer’s instructions were used. 
Mitogen stimulation served as an intrinsic control for 
blood sample quality. An IFN-γ concentration of ≥ 0.35 
IU/ml (after subtraction of nil control IFN-γ), following 
exposure to MTB Ags was considered positive for 
QFT-GIT; a concentration of < 0.35 IU/ml was considered 
negative. If the IFN-γ response to mitogen was < 0.5 
IU/ml higher than that for the nil control, or > 8 IU/ml 
higher than that for the nil control, the result was deemed 
indeterminate (Mori T et al., 2004).
Total RNA isolation and cDNA Synthesis (reverse 
transcription)
After Ag stimulation, all RNA in the whole blood 
sample was isolated by the column and centrifugation. It 
needs red blood cells (RBCs) lysis prior to white blood 
cells (WBCs) lysis. Shortly, 3 volumes of RBC lysis 
buffer (Qiagen, Amsterdam, Netherland) were added to 1 
volume of blood cell pellet and incubate onice for 10 to 
15 min. After incubation, samples centrifuged at 400 xg 
for 10 min at 4℃. After removal of supernatant, 2 
volumes of RBC lysis buffer were added to remaining 
blood cell pellet and mixed very well. Samples 
centrifuged at 400 xg for 10 min at 4℃ and removed the 
supernatant completely. After removal of RBC, the total 
RNA from WBCs was isolated with column-based 
commercial total RNA kits, QIAamp RNA Blood Mini 
kit (Qiagen, Amsterdam, Netherland) and easy-spin Total 
RNA Extraction kit (Intron Biotechnology, Seoul, Republic 
of Korea), were used according with manufacturer’s 
recommendation.
Complementary DNA (cDNA) was synthesized by 
M-MLV Reverse Transcriptase kit (Invitrogen, Carlsbad, 
CA, USA) and random hexamers (Invitrogen, Carlsbad, CA, 
USA) according with manufacturer’s recommendations. 
Reverse transcription PCR (RT-PCR)
For amplification of IFN-γ target gene and 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
endogenous control gene, the amplification mixture 
contained primers (10 pmol/μl each), 1.5 units of Taq 
DNA polymerase (SolGent, Daejeon, Republic of Korea), 
2 mM of MgCl2, 250 μM dNTP, and 3 μl of cDNA in 
a final volume 20 μl. 
RT-PCR condition to amplify the IFN-γ gene consisted 
of an initial denaturation step of 5 min at 95℃ ; 35 cycles 
comprising 30 sec at 95℃ denaturation, 30 sec at 55℃ 
primer annealing, and 30 sec at 72℃ extension; and a 
final extension at 72℃ for 7 min. RT-PCR condition to 
amplify the GAPDH gene consisted of an initial 
denaturation step of 5 min at 95℃; 23 cycles comprising 
30 sec at 95℃ denaturation, 30 sec at 55℃ primer 
annealing, and 30 sec at 72℃ extension; and a final 
extension at 72℃ for 7 min.
Semi-quantitaion of PCR products
Following PCR amplification of IFN-γ and GAPDH 
gene, amplified PCR products were analyzed by 1.8% 
Tris-borate-ethylenediaminne-tetraacetic acid disodium 
salt dehydrate (TBE) agarose gel electrophoresis and 
ethidium bromide (EtBr) staining. Stained gels were 
placed on the UV transilluminator (302 nm) and 
photographed with Molecular ImageⓇGel DocTM XR+ 
system (Bio-Rad, Hercules, CA, USA) then the results 
were analyzed by densitometer analyzing system, 
Quantity-one software (Bio-Rad, Hercules, CA, USA). 
The expression level of the IFN-γ gene was compensated 
with endogenous reference gene, GAPDH. The expression 
ratio (R) of target gene (IFN-γ) relative to a reference 
endogenous gene (GAPDH) in a MTB Ag control relative 
to nil control was calculated by following equation 
(Tetsuro H et al., 2000). 
R = density of target gene (MTB Ag - Nil) / density of 
endogenous control (MTB Ag - Nil)
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Active TB Non-TB
No. of subjects
Median age (Range)
M/F ratio
12
70 (32 ~ 79)
6 : 6
27
55 (15 ~ 84)
11 : 15
TB = tuberculosis; M = male; F = female.
Table 1. Baseline characteristics of study subjects
Study subjects (n)
Results of QFT-GIT (IGRA)
Positive, n (%) Negative, n (%) Indeterminate, n (%)
Active TB (12) 11 (91.7%) 1 (8.3%) 0 (0.0%)
Non-TB (27) 10 (37.0) 13 (48.2%) 4 (14.8%)
QFT-GIT = QuantiFERON-TB Gold In-tube test.
Table 2. QFT-GIT results of study subjects
Statistical analysis
Data were analyzed using GraphPad Prism version 
5.00 (GraphPad Software, San Diego, CA, USA). 
Positivities and negativities for MTB infection, together 
with 95% confidence intervals (CIs), were calculated as 
proportions of positive and negative cases among active 
TB patients and non-TB (healthy) control subjects, 
respectively. Nonparametric statistics, Spearman’s 
ranked correlation coefficient was employed. When 
testing for differences, a value of P = 0.05 was used as 
the criterion for statistical significance.
RESULTS
Baseline characteristics of study subjects
A total of 39 study subjects were enrolled for the 
study. They were composed of 12 active TB patients and 
27 non-TB subjects. The median age of active TB 
patients was 70 years (range 32-79) and that of non-TB 
subjects was 55 years (range 15-84). The male-to-female 
rates were 6 : 6 and 11:15 for the active TB patients and 
non-TB subjects, respectively (Table 1). 
Results of IFN-γ ELISA (QFT-GIT)
In order to measure the IFN-γ protein level after 
stimulation of MTB specific Ags, 3 ml of whole blood 
was collected from each study subject and, blood was 
treated with MTB specific Ags using commercial MTB 
specific Ag coated tubes, QFT-GIT test (Cellestics, Vic, 
Australia) for 16 to 24 hr. Ag treated blood was 
centrifuged (400 xg) and then plasma was used for 
performing ELISA to quantitate the IFN-γ protein level. 
The cut-off value (TB Ag control - nil control = 0.35 
IU/ml) for this study was established by manufacturer’s 
recommendation. Of 12 active TB patients, 11 (91.7%) 
were positives (0.35 to 25.41 IU/ml) and 1 (8.3%) was 
negative (-1.02 IU/ml) in QFT-GIT. Of 27 non-TB 
subjects group, 10 (37.0%) were positives (0.44 to 14.99 
IU/ml), 4 (14.8%) were indeterminates (-15.00 to -0.06 
IU/ml), and 13 (48.2%) were negatives (-2.04 to 0.07 
IU/ml) in QFT-GIT (Table 2). 
IFN-γ mRNA RT-PCR results between the blood 
samples from active TB patients and non-TB subjects 
group
In order to quantitate the IFN-γ mRNA expression 
levels after stimulation of MTB specific Ags, 3 ml of 
whole blood was collected from each study subject and 
blood was treated with MTB specific Ags using 
commercial MTB specific Ag coated tubes, QFT-GIT test 
for 4 hr. Ag treated blood was centrifuged (400 xg) and 
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Fig. 1. The IFN-γ mRNA 
RT-PCR results in active TB 
patients blood samples (A, B) 
and non-TB subjects blood 
samples (C, D). 
then blood cell pellets were used for performing IFN-γ 
mRNA RT-PCR. Separated blood cell pellets were lysed 
to extract total RNA using QIAamp RNA Blood Mini kit 
(Qiagen, Amsterdam, Netherland) and easy-spin Total 
RNA Extraction kit (Intron Biotechnology, Seoul, 
Republic of Korea), then extracted total RNA was used 
for reverse transcription using M-MLV RT and random 
hexamers (Invitrogen, Carlsbad, CA, USA). After 
performing the IFN-γ mRNA RT-PCR, the IFN-γ mRNA 
expression patterns between in active TB patients’ and 
non TB (healthy) subjects’ blood samples were compared 
(Fig. 1). The IFN-γ mRNA expression levels of MTB Ag 
control relative to nil control in active TB patients blood 
samples (Fig. 1-A, B) were significantly higher than that 
of non-TB subjects’ blood samples (Fig. 1-C, D). 
Comparison of the correlation coefficient analysis 
between IFN-γ mRNA expression and protein level 
(4 hr vs. 24 hr)
To investigate the correlation between IFN-γ mRNA 
expression (4 and 24 hr) and protein levels (24 hr) after 
stimulation with MTB specific Ags (ESAT-6, CFP-10 
and TB7.7), the IFN-γ mRNA expression levels were 
compared to IFN-γ protein levels in each sample. The 
IFN-γ mRNA expression levels were measured by 
RT-PCR after MTB specific Ag stimulation for both 4 
and 24 hr and, IFN-γ protein levels were measured by 
IFN-γ ELISA after MTB specific Ag stimulation for 24 
hr. The correlation coefficient between IFN-γ mRNA 
expression and IFN-γ protein level was analyzed by 
Spearman correlation coefficient test. The Spearman r 
and p value between IFN-γ mRNA expression (4 hr) and 
protein levels (24 hr) was 0.7 and <0.0001 respectively 
(Fig. 2-A). The Spearman r and P value between IFN-γ 
mRNA expression (24 hr) and protein levels (24 hr) was 
0.4 and 0.0097 (Fig. 2-B). These results show that the 
correlation between IFN-γ mRNA expression (4 and 24 
hr) and protein levels (24 hr) after MTB specific Ag 
stimulation was statistically significant. However, in order 
to perform the IFN-γ mRNA RT-PCR, 4 hr was more 
optimal Ag stimulation time.  
Comparison of IFN-γ mRNA RT-PCR (4 and 24 
hr) results with IFN-γ ELISA (QFT-IT) results 
To compare the IFN-γ mRNA RT-PCR results in 
different MTB specific Ag stimulation time (4 and 24 hr), 
IFN-γ mRNA RT-PCR was performed after MTB 
specific Ag stimulation in two time points (4 and 24 hr) 
and, the results were compared with commercial IFN-γ 
assay (QFT-GIT). Among 20 QFT-GIT positive samples, 
18 (90.0%) were positive and 2 (10.0%) were negative 
when performed RT-PCR after Ag stimulation for 4 hr, 
and 11 (55.0%) were positive and 9 (45.0%) were 
negative when stimulating with MTB specific Ag for 24 
hr. Among 4 QFT-GIT indeterminate samples, 2 (50.0%) 
were positive and 2 (50.0%) were negative when 
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IFN-γ ELISA 
(QFT-GIT) No. of cases
IFN-γ RT-PCR (4 hr) IFN-γ RT-PCR (24 hr) 
Results No. of detection Results No. of detection
 Positive 20 Positive Negative
18
 2
Positive 
Negative
11
 9
Indeterminate  4 Positive 
Negative 
 2
 2
Positive 
Negative
 1
 3
Negative 13 Positive 
Negative
 2
12
Positive 
Negative
 2
13
Total 39 39 39
Table 2. Comparison of IFN-γ mRNA RT-PCR results with QFT-GIT results (QFT-GIT positive, QFT-GIT indeterminate, 
QFT-GIT negative) according to the MTB specific antigen stimulation time (4 and 24 hr).
 
Number of XY Pairs
Spearman r
95% confidence interval
P value(two-tailed)
P value summary
Exact or approximate P value?
Is the correlation significant?(alpha=0.05)
39
0.7
0.4 to 0.8
<0.0001
***
Gaussian Approximation
Yes
Number of XY Pairs
Spearman r
95% confidence interval
P value(two-tailed)
P value summary
Exact or approximate P value?
Is the correlation significant?(alpha=0.05)
39
0.4
0.1 to 0.6
0.0097
**
Gaussian Approximation
Yes
Fig. 2. The correlation coefficient analysis between IFN-γ mRNA expression (4 hr) and protein level (A), and IFN-γ mRNA
expression (24 hr) and protein level (B) after stimulation of MTB specific antigens. 
performing RT-PCR after Ag stimulation for 4, and 1 
(25.0%) was positive and 3 (75.0%) were negative when 
performing RT-PCR after Ag stimulation for 24 hr. 
Among 15 QFT-GIT negative samples, 2 (13.3%) were 
positive and 13 (86.7%) were negative when performing 
RT-PCR after Ag stimulation for both 4 and 24 hr (Table 
3). The coincident rate between QFT-GIT and IFN-γ 
RT-PCR (4 hr) was 88.4%, and The coincident rate 
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Fig. 3. Comparison of receiver operating characteristic (ROC) curve for IFN-γ mRNA expression levels both at 4 and 24 
hr after MTB specific Ag (ESAT-6, CFP-10, TB7.7) stimulation. 
between QFT-GIT and IFN-γ RT-PCR (24 hr) was 
70.9%. This shows that IFN-γ RT-PCR (4 hr) has the 
higher coincident rate (17.5%).
To investigate the further statistical significance, 
receiver operating characteristic (ROC) curve was carried 
out. The 4 hr MTB specific Ag stimulation time for IFN-
γ RT-PCR had the significant P, 95% CI, and AUC value 
(P < 0.0001, 95% CI=0.82 to 1.02, and AUC = 0.9214) 
than 24 hr MTB specific Ag stimulation time (P = 0.009, 
95% CI = 0.06 to 0.94, and AUC = 0.7711) (Fig. 3). 
These results show that 4 hr stimulation time was the 
most optimal time for IFN-γ RT-PCR compared with the 
results with IFN-γ ELISA (QFT-GIT).
DISCUSSION
This study reports that quantitation of IFN-γ mRNA 
expression level using RT-PCR after MTB specific Ag 
stimulation at early time point was useful for detecting 
MTB infection. Although the usefulness of measuring 
IFN-γ  mRNA expression for detecting LTBI was 
demonstrated from the previous study (Bibova et al., 
2012; Kim et al., 2013), there was not a direct 
comparison between Ag stimulation times for performing 
RT-PCR. Therefore, the results of IFN-γ mRNA RT-PCR 
in different Ag stimulation time points (4 and 24 hr) were 
compared. Additionally, semi-quantitative RT-PCR was 
used for measuring IFN-γ  mRNA expression level. 
Results from this study have shown that when 
comparing the Ag stimulation times between 4 and 24 hr, 
the data showed that 4 hr provides more reliable 
information of MTB infection than 24 hr. The coincident 
rate with IFN-γ protein ELISA (QFT-GIT) and the 
statistical values from ROC curve and Spearman 
correlation test were high in RT-PCR after 4 hr 
stimulation with MTB specific Ag. These results were 
identical with the data from the previous study (Kim et 
al., 2013) which reported that the IFN-γ mRNA 
expression was measurable at early time point (4 hr). 
Furthermore, quantitation of IFN-γ mRNA expression 
with semi-quantitative RT-PCR was available too alike 
quantitative real-time PCR TaqMan assay. Therefore, it 
might be useful at a laboratory which does not have 
real-time PCR instrument. However, it has several 
limitations for accurate and rapid quantitaion of gene 
expression. As semi-quantitative RT-PCR is the end- 
point analysis, gene expression level was measured at 
after target gene amplification. Furthermore, it might be 
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more labor intensive than real-time RT-PCR because 
quantitation of gene expression by semi-quantitative 
RT-PCR has to be followed agarose gel electrophoresis, 
gel staining, and densitometer analysis. 
Overall, we conclude that optimal MTB Ag stimulation 
time for IFN-γ mRNA RT-PCR was 4 hr. Although 
semi-quantitative RT-PCR has several limitations than 
quantitative real-time PCR, quantitation of IFN-γ mRNA 
expression by semi-quantitative RT-PCR could be useful 
for the diagnosis of MTB infection.  
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